State Street Corp Biora Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 15, 2023	SELL	$2.04 - $6.7 $896,267 - $2.94 Million	-439,347 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.11 - $2.25 $372,767 - $755,610	335,827 Added 324.41%	439,347 $510,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $4.89 $5,400 - $19,560	-4,000 Reduced 3.72%	103,520 $216,000
Q3 2021 Nov 15, 2021	BUY	$0.67 - $3.41 $3,618 - $18,414	5,400 Added 5.29%	107,520 $163,000
Q2 2021 Aug 16, 2021	BUY	$2.11 - $4.93 $33,300 - $77,805	15,782 Added 18.28%	102,120 $365,000
Q1 2021 May 17, 2021	BUY	$3.91 - $7.31 $210,741 - $393,994	53,898 Added 166.15%	86,338 $411,000
Q4 2020 Feb 16, 2021	BUY	$3.27 - $9.48 $2,334 - $6,768	714 Added 2.25%	32,440 $172,000
Q3 2020 Nov 10, 2020	BUY	$7.71 - $10.79 $244,607 - $342,323	31,726 New	31,726 $286,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $312M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.